Paragon Analytics, LLC utilizes proprietary, world class AI and data mining technologies to generate valuable mass tort legal cases at a radically lower cost than other lead generation methods. We are currently pursuing six case types: NEC infant formula, mesothelioma, Roundup, hernia mesh, sexual abuse & sexual assault and Elmiron cases. We are currently raising capital from accredited investors, offering a guaranteed 2x return in 3 years (i.e., a 26 percent IRR annual return).
learn more
Our business strategy is to focus primarily on case types that are in “settlement mode” – i.e., the defendant/manufacturer has suffered so many adverse verdicts that it has decided to throw in the towel and has set aside several billion dollars – or in the case of Monsanto, more than $10 billion each – to settle those claims.
Our Current Case Types
NEC Infant formula
Necrotizing Enterocolitis (“NEC”) is caused when a pretermis fed infant formula based on cow’s milk, as opposed to mother's breast milk.
Read moreMesothelioma
Mesothelioma is a form of cancer that is caused by the inhalation of asbestos fibers, and unfortunately about 80 percent of the time is fatal.
Read moreRoundup
Roundup was a herbicide manufactured by Monsanto which in many cases causes non-Hopkin lymphoma, a type of cancer that develops in the lymphatic system.
Read moreHernia mesh
Defective hernia mesh can cause persistent pain and discomfort, infection, hernia recurrence, adhesion (internal scarring), and bowel obstruction.
Read moreSexual Abuse & Assault
Many sexual abuse cases are quite horrific — e.g., young children being abused by adults who have some level of authority and control over them.
Read moreElmiron
Long-term use Elmiron can cause distorted vision, difficulty seeing at night, vision loss, and permanent eye damage, including blindness.
Read moreProspective Investors
At Paragon Analytics, LLC, we are revolutionizing the mass tort industry by leveraging cutting-edge artificial intelligence and advanced data mining technologies to identify and generate high-value mass tort legal cases. Our innovative approach dramatically reduces the cost of lead generation, enabling us to deliver significant returns while disrupting traditional methods in the industry.
We are currently raising capital from accredited investors, offering very high returns relative to risk for those looking to participate in the legal tech and mass tort space.
- A business executive with over 18 years of mass tort experience
- A Harvard-trained data scientist
- A medical coding expert with over 20 years of experience and four medical coding certifications
- A Chief Technology Officer who speaks at ernational conferences and has co-authored two books published by Microsoft Press
- An AI expert with over 30 years of AI and IT experience